Pharmacotherapeutic group: Corticosteroids for dermatological use. ATX code D07A C01.
active substance: betamethasone;
1 g of cream contains betamethasone dipropionate * 0.64 mg Excipients: methylparaben (methyl parahydroxybenzoate) (E 218) 2 mg imidourea 5 mg propylene glycol; glycerin mineral oil; white soft paraffin; dimethicone; cetostearyl alcohol; polyethylene glycol (macrogol) cetostearyl ether; sodium dihydrogen phosphate monohydrate, diluted phosphoric acid; purified water. * – betamethasone dipropionate, in terms of 100% substance.
Betamethasone is contraindicated for patients with allergic reactions to any of the components of the drug. Drug is contraindicated in the following cases: viral infections, including post-vaccination reactions and chickenpox; viral skin infections (eg, herpes simplex, shingles, chickenpox); rosacea; rosacea-like (perioral) dermatitis – bacterial dermatoses, including tuberculosis and skin syphilis; fungal diseases; ophthalmic diseases (Betamethasone is not intended for ophthalmic use). It is not recommended to use Betamethasone cream under occlusive dressings (gypsum, etc.). Special care should be taken when applying drug to the face. Do not allow the drug to come into contact with eyes or mucous membranes. Long-term treatment and / or application on a large surface of the skin should be avoided, since absorption of the active substance is possible. You should not use the cream in the first trimester of pregnancy (see section “Use during pregnancy or lactation”).